在结肠直肠腺瘤 - 癌症的进展中,作为预后标志物,瘤和相邻的粘膜之间的PCNA表达差异是结肠直肠腺瘤 - 癌症的进展

Revekka Harisi1,2,3, Balazs Jaray4, Attila Zsirka5

  • 11 Institute of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, Budapest, Hungary; harisi.revekka@semmelweis.hu.

Anticancer research
|September 26, 2025
PubMed
概括

增殖细胞核抗原表达差异 (PCNA-ED) 是结直肠瘤进展的重要指标. 较高的PCNA-ED与恶性瘤增加,复发和较差的存活率相关,有助于预后.